Quintiles  was named 4th in the InformationWeek 500 technology innovators rankings for its Infosario platform. The company was also recognized as the industry leader in the biotech and pharmaceutical category.

The company’s Infosario introduced in June this year, is an end-to-end business platform that empowers  biopharma customers to manage data. It enables fast, smart decision making, which accelerates drug development and significantly reduces operating costs,” said Richard Thomas, chief information officer, Quintiles.

With nearly three decades of drug development and commercialization experience, Quintiles was recognized for creating a compelling proposition to support the biopharma industry, building a bridge to the future where data is foundational.

“Over the last few years, we have been  assembling the portfolio of clinical applications and patented technologies that we use internally, integrating and then virtualizing them as they are housed in our private cloud,” said Naz Haji, senior vice president, technology client services, Quintiles.

InformationWeek identifies United States’ innovative users of information technology with its annual 500 listing, and also tracks the technology, strategies, investments and administrative practices of America’s best-known companies.